xPharma AI

xPharma is building the transaction layer for biotech assets. Drug programs sit stranded inside universities, small biotechs, and shelved pharma pipelines because finding them, diligencing them, and pricing them is slow and relationship-bound work. xPharma verifies and structures those assets so they can actually be licensed, funded, or acquired.

The company describes it as the fastest path from molecule to medicine. Another way to say it is liquidity for science.